Characterization of Escherichia coli isolated from urinary tract infection and association between virulence expression and antimicrobial susceptibility

BMC Microbiol. 2022 Apr 6;22(1):89. doi: 10.1186/s12866-022-02506-0.

Abstract

Background: The capacity of antibiotics to modulate bacterial virulence has raised concerns over the appropriateness of antibiotic therapies, including when dosing strategies fall below sub-therapeutic levels. In this work, we investigated the ability of antibiotics to influence virulence in Escherichia coli isolated from urinary tract infection (UTI).

Results: Out of 120 isolates, 32.5% carried pap, 21.7% carried hlyA, and 17.5% carried cnf. The predominant B2 phylogroup was significantly associated with the quinolone-resistant isolates. A significant association was seen between the presence of hlyA hemolysin and susceptibility to ceftriaxone and ciprofloxacin (P < 0.05). Sub-inhibitory concentrations of both antibiotics reduced the levels of hlyA expression and hemolysis in isolates treated with antibiotics compared to untreated isolates (P < 0.05). Growth rate assay showed that the decrease in hlyA expression was not an effect of decreased growth rate.

Conclusion: Our study indicated the inhibitory effect of ciprofloxacin and ceftriaxone on the level of hemolysis, suggesting that the sub-inhibitory concentrations of these antibiotics may affect the outcome of infections. Further studies, including animal models may elucidate the outcome of virulence modulation by these antibiotics in UTI pathogenesis.

Keywords: Escherichia coli; Gene expression; Hemolysin; Minimum inhibitory concentration; Pathogenicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Ceftriaxone / pharmacology
  • Ciprofloxacin / pharmacology
  • Escherichia coli
  • Escherichia coli Infections* / microbiology
  • Hemolysis
  • Urinary Tract Infections* / microbiology
  • Virulence
  • Virulence Factors / genetics

Substances

  • Anti-Bacterial Agents
  • Virulence Factors
  • Ciprofloxacin
  • Ceftriaxone